Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 10;10(10):807.
doi: 10.3390/diagnostics10100807.

Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature

Anna Apostolopoulou  1 , Zerelda Esquer Garrigos  2   3 , Prakhar Vijayvargiya  2   3 , Alexis Hope Lerner  4 , Dimitrios Farmakiotis  4
Affiliations
Review

Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature

Anna Apostolopoulou et al. Diagnostics (Basel). .

Abstract

In this systematic review, we investigate the epidemiology, pathogenesis, risk factors, clinical manifestations, diagnosis and treatment of COVID-19-associated pulmonary aspergillosis (CAPA). We identified 85 cases from 22 studies. The frequency of CAPA is currently unknown but ranges between <5% to >30% in different case series; the possibility of colonization rather than invasive disease is the most important confounder. The vast majority of patients with CAPA did not have any of the classic host risk factors, such as immunosuppression from organ transplant or neutropenia, although a significant proportion (46%) had received corticosteroids. Age, pulmonary comorbidities and male sex were associated with higher mortality. Patients treated with voriconazole had numerically lower case-fatality rate. Clinical vigilance for CAPA is advisable in critically ill patients with COVID-19 who are not improving, even those who do not meet classic host criteria for invasive mycoses, especially if they are receiving corticosteroids. A thorough, multi-faceted diagnostic work-up and early initiation of a mold-active triazole may be lifesaving. Further research studies using standardized, uniform definitions of invasive disease and colonization are urgently needed.

Keywords: CAPA; COVID-19; SARS-CoV-2; aspergillosis; aspergillus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Proposed pathogenesis of CAPA.
Figure 2
Figure 2
UpSet diagram of diagnostic modalities for the diagnosis of CAPA.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO Statistics. [(accessed on 26 July 2020)];2020 Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
    1. Lansbury L., Lim B., Baskaran V., Lim W.S. Co-Infections in People with COVID-19: A Systematic Review and Meta-Analysis. SSRN Electron. J. 2020;81:266–275. doi: 10.2139/ssrn.3594598. - DOI - PMC - PubMed
    1. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., Pappas P.G., Maertens J., Lortholary O., Kauffman C.A., et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 2008;46:1813–1821. doi: 10.1086/588660. - DOI - PMC - PubMed
    1. Blot S., Taccone F.S., Abeele A.-M.V.D., Bulpa P., Meersseman W., Brusselaers N., Dimopoulos G., Paiva J.A., Misset B., Rello J., et al. A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients. Am. J. Respir. Crit. Care Med. 2012;186:56–64. doi: 10.1164/rccm.201111-1978OC. - DOI - PubMed
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:10223. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed

LinkOut - more resources